论文部分内容阅读
Ｍｅｎａｒｉｎｉ公司的ＡＣＥ抑制剂佐芬普利 (ｚｏｆｅｎｏ ｐｒｉｌ ,Ｚｏｆｅｎ/Ｂｉｆｒｉｌ)在意大利首次上市 ,用于治疗高血压和急性心肌梗死。公司称该药在其他欧盟成员国上市有望很快被批准。佐芬普利在美国注册的计划也正在实施。据Ｍｅｎａｒｉｎｉ公司报道 ,它正在
Menarini’s ACE inhibitor zofeno pril (Zofeno pril, Zofen / Bifril) was first introduced in Italy for the treatment of hypertension and acute myocardial infarction. The company said the drug is expected to be approved soon in other EU member states. Zofenopril registered in the United States plan is also being implemented. According to Menarini, it is being reported